CELL DESIGN LABS, INC.
Profile
Company Names
CELL DESIGN LABS, INC.
Addresses
4165 CANYON ROAD, LAFAYETTE, CA 94549
Phone Numbers
925-310-4893
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$26,890,007.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2016-06-03
$4,000,000.00
$4,000,000.00
$0.00
Equity
1
2016-06-02
$22,890,007.00
$22,890,007.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW
ALLEN
DIRECTOR
BRIAN
ATWOOD
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ARIE
BELLDEGRUN
DIRECTOR
USHIFU LLC
| CELL DESIGN LABS, INC.
| VIDA VENTURES, LLC
| ALLOGENE THERAPEUTICS, INC.
| VVAG SPECIAL FUND LLC
| VV ATREUS SPECIAL FUND LLC
| VIDA VENTURES II, LLC
| VIDA VENTURES II-A, LLC
| 105 W FIRST STREET, L.L.C.
| BREAKTHROUGH PROPERTIES GROWTH PORTFOLIO I, L.P.
| TORREY VIEW, L.L.C.
| D3C1 ALLSTON CO-INVESTMENT, L.P.
| DQP ALLSTON CO-INVESTMENT, L.P.
| PACIFIC PLAZA REIT, L.L.C.
| 1 CANAL REIT, L.L.C.
| 2300 MARKET REIT, L.L.C.
| 1685 38TH REIT, L.L.C.
| 6220 GREENWICH DRIVE REIT, L.L.C.
| ALLSTON PHASE A RESIDENTIAL REIT, L.L.C.
| 6200 GREENWICH DRIVE REIT, L.L.C.
| ALLSTON PHASE A LAB/OFFICE REIT, L.L.C.
| ALLSTON PHASE A HOTEL REIT, L.L.C.
| PARCEL 3 REIT, L.L.C.
| 4174 SORRENTO VALLEY REIT, L.L.C.
| SYMBIOTIC CAPITAL LIFE SCIENCE CREDIT FUND, L.P.
| SYMBIOTIC CAPITAL LIFE SCIENCE CREDIT PARALLEL FUND, L.P.
| 3020 CALLAN ROAD REIT, L.L.C.
| BYHEART, INC.
| SC HEALTHCARE CREDIT PARALLEL FUND II A, L.P.
| SYMBIOTIC CAPITAL HEALTHCARE CREDIT PARALLEL FUND II, L.P.
| SYMBIOTIC CAPITAL HEALTHCARE CREDIT FUND II, L.P.
| 3030 SCIENCE PARK REIT, L.L.C.
| 3040-3050 SCIENCE PARK REIT, L.L.C.
BROOK
BYERS
DIRECTOR
OPTIMEDICA CORP
| HX DIAGNOSTICS INC
| CRESCENDO BIOSCIENCE, INC.
| CARDIODX INC
| VERACYTE, INC.
| FIVE PRIME THERAPEUTICS INC
| XDX, INC.
| ELCELYX THERAPEUTICS, INC.
| FOUNDATION MEDICINE, INC.
| OCULEVE, INC.
| ENJOY TECHNOLOGY, INC.
| ZEPHYR HEALTH, INC.
| NEWSELA, INC.
| CAREDX, INC.
| CELL DESIGN LABS, INC.
| GRAIL, INC.
| OCTAVE BIOSCIENCE INC
| EPIODYNE, INC.
| ARSENAL BIOSCIENCES, INC.
FRED
COHEN
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PROTEOGENIX INC
| NODALITY INC
| NODALITY, INC.
| QUINTILES TRANSNATIONAL HOLDINGS INC.
| CARDIODX INC
| VERACYTE, INC.
| FIVE PRIME THERAPEUTICS INC
| XDX, INC.
| NOVAQUEST HEALTHCARE INVESTMENT FUND, L.P.
| REVAL HOLDINGS INC
| NOVAQUEST HEALTHCARE INVESTMENT FUND III, L.P.
| BNA CHICAGO LLC
| NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.
| ROKA BIOSCIENCE, INC.
| RAPID MICRO BIOSYSTEMS, INC.
| AUXOGYN, INC.
| CAREDX, INC.
| PROGYNY, INC.
| CELL DESIGN LABS, INC.
| CHICKEN SOUP FOR THE SOUL ENTERTAINMENT, INC.
| VIDA VENTURES, LLC
| VVAG SPECIAL FUND LLC
| ASKLEPIOS BIOPHARMACEUTICAL, INC.
| VV ATREUS SPECIAL FUND LLC
| VIDA VENTURES II, LLC
| VIDA VENTURES II-A, LLC
| ASCEND GENE + CELL THERAPIES LTD.
| FIREFLY NEUROSCIENCE, INC.
| KYVERNA THERAPEUTICS, INC.
| ASCEND ADVANCED THERAPIES GROUP, INC.
| OLLIN BIOSCIENCES, INC.
BETH
SEIDENBERG
DIRECTOR
3-V BIOSCIENCES, INC.
| HX DIAGNOSTICS INC
| IPIERIAN, INC.
| REDBRICK HEALTH CORP
| TESARO, INC.
| AUXOGYN INC
| PRACTICE FUSION INC
| SANTA MARIA BIOTHERAPEUTICS, INC.
| PINTA BIOTHERAPEUTICS, INC.
| NINA BIOTHERAPEUTICS, INC.
| BREATHE TECHNOLOGIES INC
| AUXOGYN, INC.
| FLEXUS BIOSCIENCES, INC.
| LIVONGO HEALTH, INC.
| PROGYNY, INC.
| CELL DESIGN LABS, INC.
| FLX BIO, INC.
| HIXME INSURANCE SOLUTIONS, INC.
| KINSA INC.
| BREATHE ACQUISITION CORP.
| BREATHE TECHNOLOGIES, INC.
| WESTLAKE BIOPARTNERS FUND I, L.P.
| RAPT THERAPEUTICS, INC.
| TMUNITY THERAPEUTICS, INC.
| SAGIMET BIOSCIENCES INC.
| VERA THERAPEUTICS, INC.
| WESTLAKE BIOPARTNERS OPPORTUNITY FUND I, L.P.
| ARSENAL BIOSCIENCES, INC.
| LATIGO BIOTHERAPEUTICS, INC.
| STAR THERAPEUTICS LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
